HPV Prevalence in the Dutch cervical cancer screening population (DuSC study): HPV testing using automated HC2, cobas and Aptima workflows

A Comparison of the Roche Cobas HPV Test With the Hybrid Capture 2 Test for the Detection of High-Risk Human Papillomavirus Genotypes

(2016) Angelique W. Levi et al.   ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE

Hybrid Capture 2 and cobas human papillomavirus assays perform similarly on SurePath samples from women with abnormalities

(2016) D. Fornari et al.   CYTOPATHOLOGY

A review of the clinical performance of the Aptima HPV assay

(2016) Juliane Haedicke et al.   JOURNAL OF CLINICAL VIROLOGY

Human Papillomavirus Assays and Cytology in Primary Cervical Screening of Women Aged 30 Years and Above

(2016) Matejka Rebolj et al.   PLoS One

Comparison of the Roche cobas® 4800 and Digene Hybrid Capture® 2 HPV tests for primary cervical cancer screening in the HPV FOCAL trial

(2015) Darrel A. Cook et al.   BMC CANCER

Which high-risk HPV assays fulfil criteria for use in primary cervical cancer screening?

(2015) M. Arbyn et al.   CLINICAL MICROBIOLOGY AND INFECTION

Primary cervical cancer screening with human papillomavirus: End of study results from the ATHENA study using HPV as the first-line screening test

(2015) Thomas C. Wright et al.   GYNECOLOGIC ONCOLOGY

Disagreement between Human Papillomavirus Assays: An Unexpected Challenge for the Choice of an Assay in Primary Cervical Screening

(2014) Matejka Rebolj et al.   PLoS One

Comparing the performance of six human papillomavirus tests in a screening population

(2013) J Cuzick et al.   BRITISH JOURNAL OF CANCER

Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials

(2013) Guglielmo Ronco et al.   LANCET

HPV Testing by cobas HPV Test in a Population from Catalonia

(2013) Belén Lloveras et al.   PLoS One

Prevalence of Human Papillomavirus in 5,072 Consecutive Cervical SurePath Samples Evaluated with the Roche Cobas HPV Real-Time PCR Assay

(2013) Sarah Preisler et al.   PLoS One

Evaluation of 14 triage strategies for HPV DNA-positive women in population-based cervical screening

(2011) Dorien C. Rijkaart et al.   INTERNATIONAL JOURNAL OF CANCER

Clinical Validation of the cobas 4800 HPV Test for Cervical Screening Purposes

(2011) D. A. M. Heideman et al.   JOURNAL OF CLINICAL MICROBIOLOGY

A randomized controlled trial of Human Papillomavirus (HPV) testing for cervicalcancer screening: trial design and preliminary results (HPV FOCAL Trial)

(2010) Gina S Ogilvie et al.   BMC CANCER

Effect of Nerve-Sparing Radical Hysterectomy on Bladder Function Recovery and Quality of Life in Patients With Cervical Carcinoma

(2010) Jiahan Wu et al.   INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER

Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial

(2010) Guglielmo Ronco et al.   LANCET ONCOLOGY

Validation of high-risk HPV tests for primary cervical screening

(2009) C.J.L.M. Meijer et al.   JOURNAL OF CLINICAL VIROLOGY

Efficiency of the APTIMA® HPV Assay for detection of HPV RNA and DNA targets

(2009) Damon Getman et al.   JOURNAL OF CLINICAL VIROLOGY

Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30 years and older

(2008) Chris J.L.M. Meijer et al.   INTERNATIONAL JOURNAL OF CANCER